Neopharm Appoints Kim Yang-su as New CEO

[Asia Economy Reporter Yujin Cho] Neopharm announced on the 10th that it has newly appointed CEO Kim Yang-su through a board meeting.

CEO Kim has built 20 years of experience in sales and marketing, having worked at LG Household & Health Care and CJ O Shopping. Based on his deep understanding and extensive experience in the beauty industry, he has successfully led Neopharm's core business by overseeing sales and marketing since 2012.

Neopharm plans to actively seek a breakthrough through the appointment of a new CEO amid worsening external conditions caused by the COVID-19 pandemic and intense market competition.

CEO Kim stated, "We will respond agilely to the rapidly changing market environment through a younger organizational structure and corporate culture improvement," adding, "We will prepare for the post-COVID era and focus on overseas sales growth to improve profitability and enhance corporate competitiveness."

Founded in 2000, Neopharm is a beauty healthcare company that offers various skincare products based on its independently developed skin barrier technology (MLE®). It operates the sensitive skin specialized skincare brand 'Atopalm,' the skin barrier specialized dermocosmetic brand 'Real Barrier,' and the daily moisturizing body care brand 'Dermabee.'

This content was produced with the assistance of AI translation services.